Epigenomics AG (LON:0QXH)
1.060
+0.178 (20.18%)
At close: Feb 25, 2026
-4.50% (1Y)
| Market Cap | 658.42K +0.1% |
| Revenue (ttm) | 20.94K |
| Net Income | -273.93K |
| EPS | -0.31 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 50 |
| Open | 1.060 |
| Previous Close | 0.882 |
| Day's Range | 1.060 - 1.060 |
| 52-Week Range | 0.882 - 1.500 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 23, 2026 |